Friedli, O.; Gasser, M.; Cusini, A.; Fulchini, R.; Vuichard-Gysin, D.; Halder Tobler, R.; Wassilew, N.; Plüss-Suard, C.; Kronenberg, A.
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics 2022, 11, 792.
https://doi.org/10.3390/antibiotics11060792
AMA Style
Friedli O, Gasser M, Cusini A, Fulchini R, Vuichard-Gysin D, Halder Tobler R, Wassilew N, Plüss-Suard C, Kronenberg A.
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics. 2022; 11(6):792.
https://doi.org/10.3390/antibiotics11060792
Chicago/Turabian Style
Friedli, Olivier, Michael Gasser, Alexia Cusini, Rosamaria Fulchini, Danielle Vuichard-Gysin, Roswitha Halder Tobler, Nasstasja Wassilew, Catherine Plüss-Suard, and Andreas Kronenberg.
2022. "Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland" Antibiotics 11, no. 6: 792.
https://doi.org/10.3390/antibiotics11060792
APA Style
Friedli, O., Gasser, M., Cusini, A., Fulchini, R., Vuichard-Gysin, D., Halder Tobler, R., Wassilew, N., Plüss-Suard, C., & Kronenberg, A.
(2022). Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics, 11(6), 792.
https://doi.org/10.3390/antibiotics11060792